Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy

Table 4

Logistic regression analysis of the effect of different variables on the progression of DR after propensity score matching in the SGLT2i and control groups.

Variable	OR (95% CI)	value
Age	0.978 (0.917-1.043)	0.500
Sex (female)	1.173 (0.304-4.527)	0.817
Duration of diabetes	1.007 (0.944-1.073)	0.835
Hypertension	0.236 (0.054-1.035)	0.056
CVD	1.389 (0.204-9.445)	0.737
SGLT2i	0.152 (0.034-0.674)	0.013
HbA1c	1.287 (0.916-1.809)	0.146
Total cholesterol	0.997 (0.982-1.012)	0.665
Triglycerides	0.980 (0.960-1.000)	0.050
HDL cholesterol	0.936 (0.854-1.026)	0.159
LDL cholesterol	1.003 (0.981-1.025)	0.808

Data are presented as odd ratios (95% confidence interval). CVD = cardiovascular disease; HDL = high-density lipoprotein; LDL = low-density lipoprotein; SGLT2i = sodium-glucose cotransporter 2 inhibitor. .